Preliminary studies on the anti-tumour mechanism of BAP 16 disclosed that it could induce dose-dependent cell apoptosis of HepG2 cells through down-regulating the expression of Bcl-2 and up-regulating the expression of Bax and C-Caspase-3. The gene discussed is CASP3; the disease is neoplasm.